Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucose metabolism and AD: evidence for a potential diabetes type 3
Andrea González, Camila Calfío, Macarena Churruca, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Oxidative Stress in Health and Disease
V. Prakash Reddy
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2925-2925
Open Access | Times Cited: 99
Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Ana Isabel Beltrán-Velasco, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2488-2488
Open Access | Times Cited: 66
Tirzepatide prevents neurodegeneration through multiple molecular pathways
Rosaria Anna Fontanella, Puja Ghosh, Ada Pesapane, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions
Vijay Kumar, So-Hyeon Kim, Kausik Bishayee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9540-9540
Open Access | Times Cited: 62
Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
Yixuan Wang, Hao Hu, Xinyu Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 36
Integrative metabolomics science in Alzheimer’s disease: Relevance and future perspectives
Simone Lista, Raúl González‐Domínguez, Susana López‐Ortiz, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101987-101987
Closed Access | Times Cited: 34
Hot Spots for the Use of Intranasal Insulin: Cerebral Ischemia, Brain Injury, Diabetes Mellitus, Endocrine Disorders and Postoperative Delirium
А. О. Шпаков, И. И. Зорина, К. В. Деркач
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3278-3278
Open Access | Times Cited: 29
Interleukin-17 as a key player in neuroimmunometabolism
Aaron Douglas, Brenneth Stevens, Lydia Lynch
Nature Metabolism (2023) Vol. 5, Iss. 7, pp. 1088-1100
Open Access | Times Cited: 27
Advanced glycation and glycoxidation end products in bone
Bowen Wang, Deepak Vashishth
Bone (2023) Vol. 176, pp. 116880-116880
Open Access | Times Cited: 25
Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s disease
Abdallah M. Eteleeb, Brenna C. Novotny, Carolina Soriano‐Tárraga, et al.
PLoS Biology (2024) Vol. 22, Iss. 4, pp. e3002607-e3002607
Open Access | Times Cited: 12
Comprehensive Overview of Alzheimer’s Disease: Etiological Insights and Degradation Strategies
Manish Kumar Singh, Yoonhwa Shin, Songhyun Ju, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6901-6901
Open Access | Times Cited: 12
Nrf2/Bach1 signaling axis: A promising multifaceted therapeutic strategy for Alzheimer's disease
Priyanka Soni, Sudarshana M. Sharma, Andrew A. Pieper, et al.
Neurotherapeutics (2025), pp. e00586-e00586
Open Access | Times Cited: 1
Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects
Wei Zhang, Juan I. Young, Lissette Gomez, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Neurotransmitters in Type 2 Diabetes and the Control of Systemic and Central Energy Balance
Amnah Al-Sayyar, Maha M. Hammad, Michayla R. Williams, et al.
Metabolites (2023) Vol. 13, Iss. 3, pp. 384-384
Open Access | Times Cited: 15
Effect of pesticides on phosphorylation of tau protein, and its influence on Alzheimer’s disease
Erandis D. Torres-Sánchez, Genaro Gabriel Ortíz, Emmanuel Reyes-Uribe, et al.
World Journal of Clinical Cases (2023) Vol. 11, Iss. 24, pp. 5628-5642
Open Access | Times Cited: 13
Effect of time-restricted eating and intermittent fasting on cognitive function and mental health in older adults: A systematic review
Sina Sharifi, Fatemeh Rostami, Kimia Babaei Khorzoughi, et al.
Preventive Medicine Reports (2024) Vol. 42, pp. 102757-102757
Open Access | Times Cited: 5
Astrocytes as Neuroimmunocytes in Alzheimer’s Disease: A Biochemical Tool in the Neuron–Glia Crosstalk along the Pathogenetic Pathways
Stefano Stanca, Martina Rossetti, Paolo Bongioanni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13880-13880
Open Access | Times Cited: 12
Mass spectrometry in cerebrospinal fluid uncovers association of glycolysis biomarkers with Alzheimer’s disease in a large clinical sample
Matthijs B de Geus, Shannon Leslie, TuKiet T. Lam, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Geroprotective interventions in the 3xTg mouse model of Alzheimer’s disease
Michelle M. Sonsalla, Dudley W. Lamming
GeroScience (2023) Vol. 45, Iss. 3, pp. 1343-1381
Open Access | Times Cited: 11
Exploring the interplay of glucose metabolism, insulin resistance, and neurodegenerative pathologies: insights from streptozotocin and hypoglycaemic in vitro models
Edna Grünblatt, Cristine Marie Yde Ohki, G Angelika Schmitt-Böhrer, et al.
Journal of Neural Transmission (2025)
Open Access
Una nueva propuesta: diabetes tipo 3, una revisión narrativa
Víctor Huggo Córdova Pluma, Vicente Sisto, Federico Leopoldo Rodríguez Weber, et al.
Acta Médica Grupo Ángeles (2025) Vol. 23, Iss. 1, pp. 52-58
Closed Access
Pyruvate kinase deficiency links metabolic perturbations to neurodegeneration and axonal protection
Thomas J. Waller, Catherine A. Collins, Monica Dus
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Associations Between Chrono‐Nutrition Behaviours and Cognitive Function in Middle‐Aged Adults: The NUTRICO Cross‐Sectional Cohort Study
Christiana A. Demetriou, Dona Hileti, E. Onisiphorou, et al.
Nutrition Bulletin (2025)
Open Access
Unveiling the mTOR pathway modulation by SGLT2 inhibitors: a novel approach to Alzheimer’s disease in type 2 diabetes
Prakash Ramakrishan, Jayaraman Rajangam, Shaheedha Shabudeen Mahinoor, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 3
Closed Access
Monitoring Acidification Preceding Aβ Deposition in Alzheimer's Disease
Guannan Zhu, Hong Zhang, Ruoxi Xie, et al.
Advanced Healthcare Materials (2025)
Closed Access
Page 1 - Next Page

Scroll to top